Private and White Label Supplements: Review the Product and First Order
Identify the underlying product, permitted brand changes and the work included in the first order before comparing providers.
Agree what remains unchanged and what is adapted
| Decision | Information to request | How to use the answer |
|---|---|---|
| Reference product | Current formula, specification and sample identity | Do not accept a catalogue name as the full composition. |
| Branding | Label language, artwork, trademarks and pack presentation | Identify who checks and approves each version. |
| Modification | Ingredient, flavour, serving or packaging changes | Ask whether adaptation requires new samples or evidence. |
| First order | Material minimums, setup, testing and delivery scope | Separate reusable stock commitments from consumed components. |
| Continuation | Formula rights, access to documents and change notice | Clarify what can be reordered or transferred. |
Check what changes when your brand goes on the pack
Illustrative purchasing exercise, not a customer case, test result or quotation.
A supplier offers an existing formula with a new label. The brand also wants a different flavour. Ask whether that change remains within an existing reference or requires a new sample and formula revision; the phrase “white label” does not answer it.
- Unchanged reference: Identify the composition and pack that the offer starts from.
- Brand changes: List artwork, language and retail-pack changes separately.
- Product changes: Record flavour or ingredient changes and the approval route proposed for them.
Decision output: Compare offers by their included changes and deliverables. Formula ownership and the right to move production require an explicit agreement, not a label category.
Have the quotation identify the approved specification and artwork revisions. Keep the permissions to use a formula separate from ownership of that formula. If a supplier proposes an alternative component to meet a deadline, require the appropriate review before accepting it as the same private-label product.